Singapore creates platform to capitalise on R&D growth:
This article was originally published in Clinica
In response to the swift growth of R&D in Singapore, the country has established a network that will promote the protection and commercialisation of technology-related intellectual property. The Technology Transfer Network (TTN) will provide a platform where technology transfer offices can share their expertise, IP commercialisation can be maximised and brand and thought-leadership can be enhanced. The objective is that Singapore's technological developments be knowledge-based and innovation-driven for maximum economic and social impact. TTN's founding members are Exploit Technologies Pte Ltd (Agency for Science, Technology and Research A*STAR), Nanyang Polytechnic, Nanyang Technopreneurship Center, Ngee Ann Polytechnic, Republic Polytechnic, Singapore Polytechnic and Temasek Polytechnic.
You may also be interested in...
An upturn in M&A activity across the whole healthcare sector is expected in 2021, with the COVID-19 pandemic and the associated development of a vaccine shining a light on the sector, says a recent survey by Jefferies.
Australian patients with phototoxicity due to the rare condition EPP will now have their first treatment option – provided the drug's developer, Clinuvel, secures reimbursement under the Pharmaceutical Benefits Scheme.
Roche has partnered with Regeneron and Atea, but the company continues to leverage its long legacy in infectious diseases to identify good treatment options for the novel coronavirus.